Lipid modification

This guideline covers: Adults at higher risk of heart disease, stroke or peripheral arterial disease (cardiovascular disease). Risk of cardiovascular disease increases with age, as well as in people who smoke or who have high blood pressure or high cholesterol. People with heart disease in the f ...

Read the complete summary

This guideline covers:

• Adults at higher risk of heart disease, stroke or peripheral arterial disease (cardiovascular disease). Risk of cardiovascular disease increases with age, as well as in people who smoke or who have high blood pressure or high cholesterol. People with heart disease in the family or men with a South Asian (for example, Indian, Pakistani or Bangladeshi) background are also at higher risk.
• People who have already had a heart attack, stroke or 'mini-stroke' (transient ischaemic attack or TIA).
• People who have angina or some other forms of cardiovascular disease.

The guideline doesn't cover everyone who is at increased risk of cardiovascular disease. This guideline does not include people with diabetes, those with major genetic causes of high cholesterol (familial hypercholesterolaemia) or people with chronic kidney disease, who are also at higher risk.
Responsibility for undertaking a review of this guidance at the designated review date has passed to the National Clinical Guidelines Centre for Acute and Chronic Conditions (NCGCACC). The National Collaborating Centre for Primary Care is no longer active.

hide